The expression level of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptors 2 (HER2) can affect the survival rate of patients, and may help guide patient treatment and predict prognosis of breast cancer. This evidence concerns the gene PGR and breast carcinoma.